Hiray Pharma Solutions has an industry-leading one-stop HPAPI platform covering everything from process R&D to commercial manufacturing, providing a robust dual supply chain to our global customers.
Our HPAPI platform includes HP laboratories R&D-scale, kilo lab-scale, and an HP production plant, which is scheduled to be online in 2023. These facilities can handle HP compounds with an OEL of 10 ng/m3.
Our current HPAPI capability also includes HP milling for both wet and dry milling, including jet mill, pin mill and hammer mill. We also provide options for API production both in batch-mode and flow-mode.
